- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 307/64 - Atomes de soufre
Détention brevets de la classe C07D 307/64
Brevets de cette classe: 158
Historique des publications depuis 10 ans
|
9
|
8
|
9
|
12
|
13
|
17
|
13
|
17
|
11
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Cardioxyl Pharmaceuticals, Inc. | 49 |
16 |
| Novartis AG | 11238 |
12 |
| Allergan, Inc. | 2600 |
7 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 157 |
6 |
| The University of Queensland | 666 |
6 |
| Canopy Growth Corporation | 270 |
4 |
| ForeSee Pharmaceuticals Co., Ltd. | 37 |
4 |
| Regents of the University of Minnesota | 2620 |
4 |
| Novartis Inflammasome Research, Inc. | 10 |
4 |
| Sironix Renewables, Inc. | 15 |
4 |
| JSR Corporation | 2476 |
3 |
| Chengdu Baiyu Pharmaceutical Co., Ltd. | 69 |
3 |
| Imperial College Innovations Limited | 486 |
3 |
| Kancera AB | 31 |
3 |
| Pharmaxis Ltd | 43 |
3 |
| Oxford Drug Design Limited | 9 |
3 |
| IFM Tre, Inc. | 5 |
3 |
| BASF SE | 19740 |
2 |
| Sumitomo Chemical Company, Limited | 8808 |
2 |
| Askat Inc. | 53 |
2 |
| Autres propriétaires | 64 |